These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. [Obstetrical and hematological problems in a pregnant woman with intermediate beta-thalassemia]. Dolfin G; Lumare A; Tinetti E; Monetti C; Jacob R; Martoglio G Minerva Ginecol; 1983 Apr; 35(4):227-30. PubMed ID: 6888795 [No Abstract] [Full Text] [Related]
24. Quality of life in transfusion-dependent thalassaemia patients on desferrioxamine treatment. Dahlui M; Hishamshah MI; Rahman AJ; Aljunid SM Singapore Med J; 2009 Aug; 50(8):794-9. PubMed ID: 19710979 [TBL] [Abstract][Full Text] [Related]
25. A successful pregnancy outcome in transfusion dependent thalassaemia major. Meadows K Aust N Z J Obstet Gynaecol; 1984 Feb; 24(1):43-4. PubMed ID: 6588961 [TBL] [Abstract][Full Text] [Related]
26. [Our experience with "supertransfusive" treatment of homozygous beta-thalassemia]. Esposito L; Ferrara M; Ponte G Pediatria (Napoli); 1983; 91(1):27-30. PubMed ID: 6889088 [No Abstract] [Full Text] [Related]
27. Endocrine complications in thalassaemia major. De Sanctis V; Vullo C; Katz M; Wonke B; Hoffbrand VA; Di Palma A; Bagni B Prog Clin Biol Res; 1989; 309():77-83. PubMed ID: 2780752 [No Abstract] [Full Text] [Related]
28. Pituitary-thyroid function in children with beta-thalassaemia major. Cavallo L; Mautone A; Altomare M; Licciulli M; Pascazio A; Schettini F Acta Endocrinol (Copenh); 1981 Jan; 96(1):59-64. PubMed ID: 6779476 [No Abstract] [Full Text] [Related]
29. [Use of desferrioxamine B in the treatment of post-transfusion hypersiderosis]. Orsini A; Giraud F; Bernard P; Passeron P Mars Med; 1965; 102(7):591-5. PubMed ID: 5855127 [No Abstract] [Full Text] [Related]
30. Iron metabolism and iron chelation in the thalassaemia disorders. Pippard MJ Haematologica; 1990; 75 Suppl 5():66-71. PubMed ID: 2086383 [No Abstract] [Full Text] [Related]
31. The prevention of thalassemia in Sardinia. Cao A; Rosatelli C; Galanello R; Monni G; Olla G; Cossu P; Ristaldi MS Clin Genet; 1989 Nov; 36(5):277-85. PubMed ID: 2598483 [TBL] [Abstract][Full Text] [Related]
32. Prenatal control of severe thalassaemia: Chiang Mai strategy. Tongsong T; Wanapirak C; Sirivatanapa P; Sanguansermsri T; Sirichotiyakul S; Piyamongkol W; Chanprapaph P Prenat Diagn; 2000 Mar; 20(3):229-34. PubMed ID: 10719327 [TBL] [Abstract][Full Text] [Related]
33. Prenatal diagnosis of hemoglobinopathies in Ontario, Canada. Basran RK; Patterson M; Walker L; Nakamura LM; Eng B; Chui DH; Waye JS Ann N Y Acad Sci; 2005; 1054():507-10. PubMed ID: 16339708 [TBL] [Abstract][Full Text] [Related]
37. Medical management of beta-thalassemia. Lerner N Prog Clin Biol Res; 1989; 309():13-22. PubMed ID: 2780747 [No Abstract] [Full Text] [Related]
38. [Current treatment of Cooley's disease]. Orsini A; Perrimond H; Mattei M Ann Pediatr (Paris); 1985 Nov; 32(9):769-78. PubMed ID: 4091448 [No Abstract] [Full Text] [Related]
39. Attitudes towards prenatal diagnosis and termination of pregnancy for thalassaemia in pregnant Pakistani women in the North of England. Ahmed S; Green JM; Hewison J Prenat Diagn; 2006 Mar; 26(3):248-57. PubMed ID: 16475227 [TBL] [Abstract][Full Text] [Related]
40. [The prevention of beta-thalassemia homozygosity]. Vullo C; Lucci M; Toffoli C Recenti Prog Med; 1992 Jan; 83(1):46-55. PubMed ID: 1561483 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]